I have a persistent dry cough for two months and nocturnal achy restless legs; what workup and treatment should be considered?

Evaluation and Management of Persistent Dry Cough with Restless Legs

Gabapentin is the optimal single agent to treat both your persistent dry cough and restless legs syndrome, starting at 300 mg daily and titrating up to 1800 mg daily in divided doses as tolerated.

This recommendation leverages the unique overlap in treatment guidelines: gabapentin has strong evidence for restless legs syndrome (RLS) and is also recommended for unexplained chronic cough (UCC), making it an ideal choice when both conditions coexist 1.

Initial Workup Strategy

For the Chronic Cough (>8 weeks duration):

Essential initial tests:

• Chest radiograph to exclude malignancy, infection, or inflammatory conditions 2
• Spirometry with bronchodilator response 1
• Exhaled nitric oxide measurement 3
• Blood eosinophil count 3

Key history elements to elicit:

• Smoking status and angiotensin-converting enzyme (ACE) inhibitor use—both must be stopped if present 3
• Symptoms of gastroesophageal reflux disease (GERD), postnasal drip, or asthma 2
• Triggers such as cold air, perfumes, smoke, or bleach suggesting cough hypersensitivity 4

The diagnostic approach should focus on the five most common causes: asthma, chronic obstructive pulmonary disease, nonasthmatic eosinophilic bronchitis, GERD, and upper airway cough syndrome 3. If initial testing for bronchial hyperresponsiveness and eosinophilic bronchitis is negative, and empiric treatment for these conditions fails after 4-6 weeks, the cough is classified as unexplained chronic cough 1.

For the Restless Legs:

Mandatory laboratory testing:

• Serum ferritin level 1, 5
• Transferrin saturation 1, 5

Clinical diagnostic criteria to confirm RLS:

• Urge to move legs when at rest, often with achy or unpleasant sensations 5
• Relief with movement or walking 5
• Symptoms worse in evening/night 5
• Not better explained by leg cramps, positional discomfort, or neuropathy 1

Critical point: Polysomnography is NOT recommended for RLS diagnosis 5. The diagnosis is purely clinical based on the above criteria.

Treatment Algorithm

Step 1: Address Iron Status and Medication Review

Iron supplementation is indicated if:

• Ferritin ≤100 ng/mL OR transferrin saturation <20% 5
• Use ferrous sulfate 325-650 mg daily or every other day 5, 1
• For severe symptoms with low iron indices, consider IV ferric carboxymaltose 1000 mg (strong recommendation) 1

Medication review:

• Discontinue ACE inhibitors if present (for cough) 3
• Stop serotonergic antidepressants, dopamine antagonists, and centrally acting H1 antihistamines like diphenhydramine if present (for RLS) 5

Step 2: Initiate Gabapentin as First-Line Therapy

Gabapentin dosing schedule:

• Start 300 mg once daily at bedtime 1
• Increase by 300 mg every 3-7 days as tolerated 1
• Target dose: 1800 mg daily in 2-3 divided doses (600 mg three times daily or 900 mg twice daily) 1
• Maximum benefit for RLS seen at approximately 70% response rate versus 40% with placebo 5

This addresses both conditions simultaneously: The American College of Chest Physicians suggests gabapentin for unexplained chronic cough (Grade 2C), and the American Academy of Sleep Medicine strongly recommends gabapentin for RLS (strong recommendation, moderate certainty) 1.

Important counseling points:

• Discuss potential side effects: sedation, dizziness, peripheral edema 1
• Reassess risk-benefit profile at 6 months before continuing 1
• Sedation may actually benefit sleep quality in this patient with nocturnal restlessness 1

Step 3: Alternative or Adjunctive Therapies if Gabapentin Insufficient

For persistent cough despite gabapentin:

• Multimodality speech pathology therapy (cough suppression techniques) is suggested as it improves cough severity and quality of life 1
• Low-dose morphine (5-10 mg daily) is highly effective for refractory cough but reserve for severe cases 4, 3

For persistent RLS despite gabapentin:

• Pregabalin 150-450 mg daily (strong recommendation, alternative to gabapentin) 1
• Gabapentin enacarbil 600-1200 mg daily (strong recommendation, prodrug with better bioavailability) 1
• Low-dose opioids (methadone 5-10 mg daily or oxycodone extended-release) for refractory cases 5, 1

Step 4: What NOT to Do

Avoid these common pitfalls:

For unexplained chronic cough:

• Do NOT prescribe inhaled corticosteroids if tests for bronchial hyperresponsiveness and eosinophilia are negative (Grade 2B) 1
• Do NOT prescribe proton pump inhibitors if workup for acid reflux is negative (Grade 2C) 1

For RLS:

• Do NOT use dopamine agonists (pramipexole, ropinirole, rotigotine) as first-line therapy—they carry 7-10% annual risk of augmentation (iatrogenic worsening of symptoms) 5, 1
• Do NOT use benzodiazepines like clonazepam (conditional recommendation against) 1
• Do NOT use bupropion, carbamazepine, or valproic acid 1

Monitoring and Follow-Up

At 4-6 weeks:

• Assess cough severity using validated instruments 3
• Evaluate RLS symptom improvement and sleep quality 1
• Adjust gabapentin dose if inadequate response and tolerability allows 1

At 6 months:

• Mandatory reassessment of gabapentin risk-benefit profile 1
• Recheck iron studies if RLS symptoms worsen 6
• Consider referral to pulmonology for refractory cough or sleep medicine for refractory RLS 2

Special Considerations

The convergence of these two conditions is clinically advantageous because gabapentin addresses both the neuronal hypersensitivity underlying unexplained chronic cough and the central nervous system mechanisms in RLS 4, 1. This avoids polypharmacy and potential drug interactions.

Quality of life impact: Both conditions severely impair quality of life—RLS patients have elevated rates of depression (30.4%) and cardiovascular disease (29.6%), while chronic cough causes significant distress 5, 1. Effective treatment with a single agent optimizes adherence and outcomes.

Red flags requiring urgent evaluation:

• Hemoptysis, weight loss, or night sweats (for cough) 3
• Unilateral leg symptoms or symptoms only with specific positions (suggests alternative diagnosis to RLS) 1